Sökning: WFRF:(Sund Fredrik) > (2020-2024) > Targeting collagen ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03716naa a2200613 4500 | |
001 | oai:gup.ub.gu.se/332911 | |
003 | SwePub | |
008 | 240528s2023 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3329112 URI |
024 | 7 | a https://doi.org/10.1172/jci1591812 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Devarajan, R.4 aut |
245 | 1 0 | a Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models |
264 | 1 | c 2023 |
520 | a The tumor extracellular matrix (ECM) critically regulates cancer progression and treatment response. Expression of the basement membrane component collagen XVIII (ColXVIII) is induced in solid tumors, but its involvement in tumorigenesis has remained elusive. We show here that ColXVIII was markedly upregulated in human breast cancer (BC) and was closely associated with a poor prognosis in high-grade BCs. We discovered a role for ColXVIII as a modulator of epidermal growth factor receptor tyrosine kinase (ErbB) signaling and show that it forms a complex with ErbB1 and-2 (also known as EGFR and human epidermal growth factor receptor 2 [HER2]) and alpha 6-integrin to promote cancer cell proliferation in a pathway involving its N-terminal portion and the MAPK/ERK1/2 and PI3K/AKT cascades. Studies using Col18a1 mouse models crossed with the mouse mammary tumor virus-polyoma virus middle T antigen (MMTV-PyMT) mammary carcinogenesis model showed that ColXVIII promoted BC growth and metastasis in a tumor cell-autonomous manner. Moreover, the number of mammary cancer stem cells was significantly reduced in the MMTV-PyMT and human cell models upon ColXVIII inhibition. Finally, ablation of ColXVIII substantially improved the efficacy of ErbB-targeting therapies in both preclinical models. In summary, ColXVIII was found to sustain the stemness properties of BC cells and tumor progression and metastasis through ErbB signaling, suggesting that targeting ColXVIII in the tumor milieu may have important therapeutic potential. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng |
653 | a stem-cells | |
653 | a drug-resistance | |
653 | a mechanisms | |
653 | a expression | |
653 | a trastuzumab | |
653 | a metastasis | |
653 | a receptors | |
653 | a integrins | |
653 | a survival | |
653 | a isoforms | |
653 | a Research & Experimental Medicine | |
700 | 1 | a Izzi, V.4 aut |
700 | 1 | a Peltoketo, H.4 aut |
700 | 1 | a Rask, G.4 aut |
700 | 1 | a Kauppila, S.4 aut |
700 | 1 | a Väisänen, M. R.4 aut |
700 | 1 | a Ruotsalainen, H.4 aut |
700 | 1 | a Martinez-Nieto, G.4 aut |
700 | 1 | a Karppinen, S. M.4 aut |
700 | 1 | a Väisänen, T.4 aut |
700 | 1 | a Kaur, I.4 aut |
700 | 1 | a Koivunen, J.4 aut |
700 | 1 | a Sasaki, T.4 aut |
700 | 1 | a Winqvist, R.4 aut |
700 | 1 | a Manninen, A.4 aut |
700 | 1 | a Wärnberg, Fredriku Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för kirurgi,Institute of Clinical Sciences, Department of Surgery4 aut0 (Swepub:gu)xwarnf |
700 | 1 | a Sund, M.4 aut |
700 | 1 | a Pihlajaniemi, T.4 aut |
700 | 1 | a Heljasvaara, R.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för kirurgi4 org |
773 | 0 | t Journal of Clinical Investigationg 133:18q 133:18x 0021-9738 |
856 | 4 8 | u https://gup.ub.gu.se/publication/332911 |
856 | 4 8 | u https://doi.org/10.1172/jci159181 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy